tru Independence’s Idexx Laboratories IDXX Stock Holding History

tru Independence’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3	Closed	-$1	–	488
2020 Q4	$1	Buy	+3	New	+$1.34K	﹤0.01%	697

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

tru Independence's IDXX Position: Q1 2021 in Review

tru Independence sold out of Idexx Laboratories (IDXX) in Q1 2021, closing a stake of 3 shares — an estimated $1 sold.

tru Independence first reported a position in IDXX in Q4 2020 and held it in 1 quarter. The position peaked at $1 in Q4 2020. 1,011 funds tracked by Wall St. Rank hold IDXX as of Q1 2021.

tru Independence reported no remaining Idexx Laboratories position as of Q1 2021 after selling out during the quarter.
tru Independence sold 3 Idexx Laboratories shares in Q1 2021, an estimated $1.
tru Independence first reported a position in Idexx Laboratories in Q4 2020 and held it in 1 quarter.
tru Independence's Idexx Laboratories position peaked at $1 in Q4 2020.
1,011 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2021.

Based on tru Independence's 13F filing for Q1 2021, filed 20 May 2021.